Beovu® (Brolucizumab) for the Treatment of wet Age-related Macular Degeneration (AMD)

BEOVU is the first FDA-approved anti-VEGFA drug available for wet AMD. Credit: Novartis.



  • Beovu®
  • BEOVU
  • BEOVU
  • BEOVU